At Veinsights, we aim to help readers understand not only the “what” of venous care, but also the evolving “why.” The recent launch of the Tier 1 pilot of the Global CHIVA Program—developed jointly by Inteleos and Dr. Smile Medical Group—offers an important opportunity to examine how structured education can influence the future of hemodynamic-guided treatment for chronic venous disease.
Why This Pilot Matters
CHIVA is a technique built on a simple but powerful idea: treat venous disorders by understanding and guiding blood flow, rather than eliminating veins unnecessarily.
While this approach has gained traction worldwide, education has not always kept pace with clinical interest. Practitioners often learn CHIVA through local workshops or individual mentorship, creating differences in how ultrasound findings are interpreted and how treatment plans are designed.
The Tier 1 pilot begins to address this gap by offering two foundational modules:
- Ultrasound Fundamentals
- Principles of Venous Hemodynamics
Both modules aim to establish a consistent starting point for anyone seeking to understand CHIVA from a hemodynamic perspective.
What the Program Offers
1. A Clear Introduction to Core Concepts
The pilot explains essential ideas—such as drainage pathways, escape points, and hemodynamic shunts—in a structured and accessible format. These concepts guide how clinicians analyze venous flow and make treatment decisions.
2. Standardized Ultrasound Techniques
Since duplex ultrasound is central to CHIVA, the program emphasizes reproducible scanning methods and interpretation strategies. This helps reduce variability between practitioners and supports more reliable clinical decision-making.
3. A Collaborative Development Model
By launching the program in a soft-pilot phase, Inteleos and Dr. Smile Medical Group invite early participants to provide feedback. This approach ensures that the final curriculum reflects real-world learning needs and clinical realities.
How This Benefits Patients and Clinicians
A more structured educational pathway has the potential to:
- improve accuracy in assessing venous flow,
- support treatment plans that preserve natural vein function,
- reduce unnecessary procedures, and
- make CHIVA knowledge more accessible to clinicians worldwide.
For patients, this means more providers who understand the value of individualized, flow-guided care.
For healthcare professionals, it provides a reliable way to build foundational skills before progressing to more advanced techniques.
Access to the Tier 1 Pilot
Clinicians and trainees interested in exploring the pilot modules can access the program at:👉 https://globalchiva.talentlms.com/plus
The platform provides immediate entry into the two foundational modules, with additional components expected to roll out through 2026.
A Step Toward Future Growth
The Tier 1 pilot is the first stage of a six-module program expected to roll out through 2026. While early in development, it sets the stage for a more unified, globally informed approach to CHIVA education—one that blends expert insight with structured learning design.
At Veinsights, we will continue following this initiative as it evolves, providing updates, expert commentary, and practical explanations to help our readers stay informed and empowered in their understanding of vein health.
Post a Comment